John C. Martin
2017 - Gilead Sciences
In 2017, John C. Martin earned a total compensation of $7.3M as Executive Chairman at Gilead Sciences, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,624,000 |
|---|---|
| Option Awards | $2,000,031 |
| Salary | $1,253,208 |
| Stock Awards | $2,423,941 |
| Other | $10,000 |
| Total | $7,311,180 |
Martin received $2.4M in stock awards, accounting for 33% of the total pay in 2017.
Martin also received $1.6M in non-equity incentive plan, $2M in option awards, $1.3M in salary and $10K in other compensation.
Rankings
In 2017, John C. Martin's compensation ranked 1,095th out of 14,666 executives tracked by ExecPay. In other words, Martin earned more than 92.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,095 out of 14,666 | 93rd |
Division Manufacturing | 367 out of 5,772 | 94th |
Major group Chemicals And Allied Products | 98 out of 2,075 | 95th |
Industry group Drugs | 66 out of 1,731 | 96th |
Industry Biological Products, Except Diagnostic Substances | 12 out of 313 | 96th |
Source: SEC filing on March 26, 2018.
Martin's colleagues
We found five more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2017.
2017
John Milligan
Gilead Sciences
Chief Executive Officer
2017
Kevin Young
Gilead Sciences
Chief Operating Officer
2017
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2017
Robin Washington
Gilead Sciences
Chief Financial Officer
2017
Gregg Alton
Gilead Sciences